Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.

Market Analysis and Insights: Global Erythromycin Market
The global Erythromycin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Erythromycin Scope and Market Size
The global Erythromycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erythromycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Erythromycin Thiocyanate
Azithromycin
Clarithromycin
Roxithromycin
Others

Segment by Application
Human Medication
Veterinary Medication

The Erythromycin market is analysed and market size information is provided by regions (countries). Segment by Application, the Erythromycin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma